Management of pyoderma gangrenosum – An update
Pyoderma gangrenosum is a neutrophilic dermatosis with distinctive clinical manifestations. It is frequently associated with systemic diseases like inflammatory bowel disease, rheumatoid arthritis and myeloproliferative diseases.
Ramesh M. Bhat
core
Successful use of spesolimab in refractory pyoderma gangrenosum. [PDF]
Lum A, Patel S, Aron J, Kartono F.
europepmc +1 more source
Peristomal pyoderma gangrenosum: a review of nursing research progress. [PDF]
Chen G +6 more
europepmc +1 more source
Pyoderma Gangrenosum Secondary to Melanotan. [PDF]
Dickson D, Hlaing Htwe S.
europepmc +1 more source
Multilesional pyoderma gangrenosum secondary to Hodgkin lymphoma. [PDF]
McDaniel K +5 more
europepmc +1 more source
A Rare Case of Pyoderma Gangrenosum Pointing to Waldenström Macroglobulinemia. [PDF]
Krishnan L, Vachon E, Mishra A, McCoy D.
europepmc +1 more source
Pyoderma gangrenosum presenting with pulmonary manifestations. [PDF]
Shidhaye A +4 more
europepmc +1 more source
Infliximab-Responsive Severe Ulcerative Colitis With Pyoderma Gangrenosum After IL-6 and IGF-1 Blockade. [PDF]
Onishi S +9 more
europepmc +1 more source
Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome treated with upadacitinib. [PDF]
Javaheri E, Chen SX.
europepmc +1 more source
Keratoscleritis and Choroidal Exudative Detachment in the Setting of Ocular Pyoderma Gangrenosum. [PDF]
Bodeen J +3 more
europepmc +1 more source

